See also: Generic Ultram ER
Ultram is a brand name of tramadol, approved by the FDA in the following formulation(s):
ULTRAM (tramadol hydrochloride - tablet; oral)
Manufacturer: JANSSEN PHARMS
Approval date: March 3, 1995
Strength(s): 50MG [RLD][AB]
Has a generic version of Ultram been approved?
A generic version of Ultram has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ultram and have been approved by the FDA:
tramadol hydrochloride tablet; oral
Manufacturer: ALPHAPHARM
Approval date: November 21, 2002
Strength(s): 50MG [AB]
Manufacturer: ALVOGEN
Approval date: November 28, 2011
Strength(s): 50MG [AB]
Manufacturer: AMNEAL PHARMS
Approval date: June 20, 2002
Strength(s): 50MG [AB]
Manufacturer: APOTEX
Approval date: July 10, 2002
Strength(s): 50MG [AB]
Manufacturer: CARACO
Approval date: June 19, 2002
Strength(s): 50MG [AB]
Manufacturer: MALLINCKRODT
Approval date: June 25, 2002
Strength(s): 50MG [AB]
Manufacturer: MUTUAL PHARM
Approval date: June 20, 2002
Strength(s): 50MG [AB]
Manufacturer: MYLAN
Approval date: June 21, 2002
Strength(s): 50MG [AB]
Manufacturer: NORTHSTAR HLTHCARE
Approval date: May 26, 2010
Strength(s): 50MG [AB]
Manufacturer: PLIVA
Approval date: July 1, 2002
Strength(s): 50MG [AB]
Manufacturer: SANDOZ
Approval date: June 25, 2002
Strength(s): 50MG [AB]
Manufacturer: TEVA
Approval date: June 19, 2002
Strength(s): 50MG [AB]
Manufacturer: WATSON LABS
Approval date: June 24, 2002
Strength(s): 50MG [AB]
Manufacturer: ZYDUS PHARMS USA INC
Approval date: January 31, 2011
Strength(s): 50MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ultram. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Analgesic regimen
Patent 6,339,105
Issued: January 15, 2002
Inventor(s): Marc; Kamin & William; Olson
Assignee(s): Ortho-McNeil Pharmaceutical, Inc.
A regimen for the administration of tramadol for the treatment of analgesia is described. The regimen involves a slower initial titration rate of tramadol which results in a significantly lower percentage of discontinuations of therapy due to a lower incidence and severity of side effects.Patent expiration dates:
- October 12, 2019✓
- April 12, 2020✓✓
- October 12, 2019
See also...
- Ultram Consumer Information (Drugs.com)
- Ultram Consumer Information (Wolters Kluwer)
- Ultram Consumer Information (Cerner Multum)
- Ultram Advanced Consumer Information (Micromedex)
- Ultram AHFS DI Monographs (ASHP)
- Tramadol Consumer Information (Drugs.com)
- Tramadol Consumer Information (Wolters Kluwer)
- Tramadol Extended-Release Capsules Consumer Information (Wolters Kluwer)
- Tramadol Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Tramadol Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
- Tramadol Consumer Information (Cerner Multum)
- FusePaq Synapryn Advanced Consumer Information (Micromedex)
- Tramadol Advanced Consumer Information (Micromedex)
- Tramadol Hydrochloride AHFS DI Monographs (ASHP)
No comments:
Post a Comment